Abingdon Health Plc (LON:ABDX – Get Free Report)’s share price traded up 2.6% on Thursday . The company traded as high as GBX 11 and last traded at GBX 10.77. Approximately 315,994 shares were traded during mid-day trading, an increase of 18% from the average daily volume of 267,036 shares. The stock had previously closed at GBX 10.50.
Abingdon Health Stock Performance
The company has a market capitalization of £26.36 million, a PE ratio of -12.96 and a beta of 0.16. The company has a debt-to-equity ratio of 15.05, a quick ratio of 1.96 and a current ratio of 1.91. The business has a fifty day moving average price of GBX 10.71 and a 200 day moving average price of GBX 9.19.
About Abingdon Health
Abingdon Health is a world leading contract developer and manufacturer (CDMO) of high-quality rapid tests across all industry sectors, including healthcare, infectious disease, animal health, environmental and self-testing. Abingdon is the partner of choice for a growing global customer base and takes projects from initial concept through to routine and large-scale manufacturing and regulatory approval. The Company also markets its own range of self-tests under the Abingdon Simply Test brand (www.abingdonsimplytest.com) and has developed and marketed its own labelled tests.
Further Reading
- Five stocks we like better than Abingdon Health
- Axon’s Post-Earnings Pullback May Be More About Valuation Than Growth
- Uber Stock Lags in 2026, But Cash Flow and AV Bets Fuel Upside
- AppLovin Stock Hits 52-Week Low as Analysts Trim Targets, Stay Bullish
- Why These 3 Equal Weight ETFs Have Outperformed the S&P This Year
Receive News & Ratings for Abingdon Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Abingdon Health and related companies with MarketBeat.com's FREE daily email newsletter.
